Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports

    February 2026 in “ Dove Medical Press (Taylor and Francis Group) ”
    Julia Młyńska, Dominika Mysiorska, Natalia Zdanowska, Agnieszka Owczarczyk-Saczonek
    Studysummary This case report highlights two instances of alopecia areata, demonstrating diverse presentations, and suggests upadacitinib as a promising treatment option, resulting in hair regrowth within 3–6 months, without worsening sarcoidosis-related skin lesions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dovepress.com →
    Discuss this study in the Community →